ABG-WTT Global Life Science Capital Partners GP Ltd Long-Term Concentrated

Name: ABG-WTT Global Life Science Capital Partners GP Ltd Q3 2022 13F Filing | 13F Explorer
Creator: ABG-WTT Global Life Science Capital Partners GP Ltd
Published: 2022-11-14

Location: Central, Hong Kong, Hong Kong

CIK: 0001832108 · Show all filings

Period: Q3 2022 (← Previous) (Next →)

Filing Date: Nov 14, 2022

Total Value: $16.02M (100.0% shares, 0.0% debt)

Holdings (3)

— MEDAVAIL HOLDINGS INC 72.8%

Value $11.66M Shares 15,029,480 Est. Cost $5.03 Unrealized —

RPID RAPID MICRO BIOSYSTEMS INC 20.9%

Value $3.354M Shares 1,038,296 Est. Cost $7.36 Unrealized -47.3%

LUNG PULMONX CORP 6.3%

Value $1.003M Shares 60,204 Est. Cost $48.97 Unrealized -62.4%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	MEDAVAIL HOLDINGS INC	15,029,480	$11.66M	72.8%	$5.03	—	COM	58406B103
RPID	RAPID MICRO BIOSYSTEMS INC	1,038,296	$3.354M	20.9%	$7.36	-47.3%	CLASS A COM	75340L104
LUNG	PULMONX CORP	60,204	$1.003M	6.3%	$48.97	-62.4%	COM	745848101